News Releases

2019-11/26
United BioPharma Signs clinical trial agreement with NIH/NIAID for sponsorship of a multi-drug resistant HIV trial with UB-421
1
2019-11/08
United BioPharma Receives US FDA Approval for UB-221 Phase 1 IND for Chronic Spontaneous Urticaria
2
2019-10/07
PharmaBoardRoom interview of Dr. Chang Yi Wang, Chairperson and Chief Scientific Officer of United Biopharma (UBP)
3
2019-09/02
United BioPharma successfully completes Taiwan FDA GMP inspection for its 2000L commercial scale manufacturing facility
4
2019-05/14
United BioPharma Receives China NMPA Approval for UB-421 Phase 3 ART-Substitution Trial in HIV-infected Patients
5
2019-04/18
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption(N Engl J Med 2019; 380:1535-1545)
6
2019-04/18
United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine
7
2019-04/18
How an Experimental Injection Could Revolutionize HIV Treatment
8
2019-06/11
United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial in Recurrent Genital Herpes Patients
9
2019-11/26
United BioPharma Signs clinical trial agreement with NIH/NIAID for sponsorship of a multi-drug resistant HIV trial with UB-421
1
2019-11/08
United BioPharma Receives US FDA Approval for UB-221 Phase 1 IND for Chronic Spontaneous Urticaria
2
2019-10/07
PharmaBoardRoom interview of Dr. Chang Yi Wang, Chairperson and Chief Scientific Officer of United Biopharma (UBP)
3
2019-09/02
United BioPharma successfully completes Taiwan FDA GMP inspection for its 2000L commercial scale manufacturing facility
4
2019-05/14
United BioPharma Receives China NMPA Approval for UB-421 Phase 3 ART-Substitution Trial in HIV-infected Patients
5
2019-04/18
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption(N Engl J Med 2019; 380:1535-1545)
6
2019-04/18
United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine
7
2019-04/18
How an Experimental Injection Could Revolutionize HIV Treatment
8
2019-06/11
United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial in Recurrent Genital Herpes Patients
9
United BioPharma was listed on the Taiwan Emerging Stock Market (Stock code : 6471) 2014-09/13
Establishment of UBP’s Clincial Research Center at the Hsinchu Biomedical Science Park 2014-05/15
United Biopharma held its opening ceremony at the 36th floor Auditorium of Taipei 101 building 2014-01/16
Establishment of a strategic alliance between UBP and Formosa Biomedical Technologies and the Chang-Gun Memorial Hospital of the Formosa Plastic Group 2013-10/30
Establishment of United BioPharma(UBP) through spinoff from its parent company United Biomedical, Asia (UBI Asia) 2013-09/30
United BioPharma, Inc. Copyright (c) 2020